Clinical Trial Update: A Phase II Efficacy Study of Roferon-A in Hairy Cell Leukemia [Phase 2]

View source ↗

Summary

Completed Phase II efficacy trial of Roferon-A (interferon alfa-2a) for hairy cell leukemia; study results addressing efficacy have been reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hairy Cell Leukemia

Drugs mentioned

• Roferon-A (interferon alfa-2a)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Hairy Cell Leukemia | Phase 2 | Status: COMPLETED